Good Quality Telaprevir Manufacturer - Dabigatran Etexilate Mesylate – CPF

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Our eternal pursuits are the attitude of "regard the market, regard the custom, regard the science" as well as the theory of "quality the basic, have confidence in the very first and management the advanced" for Lyrica Pregabalina, Rosuvastatin Calcium 20 Mg En Español, Obeticholic Acid Cost, In case you are on the lookout for a high quality, quick delivery, very best after support and great value supplier in China for long-term small business connection, we'll be your best choice.
Good Quality Telaprevir Manufacturer - Dabigatran Etexilate Mesylate – CPF Detail:

Description

Dabigatran etexilate mesylate (BIBR 1048MS) is an orally active prodrug of Dabigatran. Dabigatran etexilate mesylate has anticoagulant effects and is used for the prophylaxis of venousthromboembolism and stroke due to atrial fibrillation.

Background

Description: IC50 Value: 4.5nM (Ki); 10nM(Thrombin-induced platelet aggregation) [1] Dabigatran is a reversible and selective, direct thrombin inhibitor (DTI) undergoing advanced clinical development as its orally active prodrug,dabigatran etexilate. in vitro: Dabigatran selectively and reversibly inhibited human thrombin(Ki: 4.5 nM) as well as thrombin-induced platelet aggregation (IC(50): 10 nM), while showing no inhibitory effect on other platelet-stimulating agents.Thrombin generation in platelet-poor plasma (PPP), measured as the endogenous thrombin potential (ETP) was inhibited concentration-dependently (IC(50): 0.56 microM). Dabigatran demonstrated concentration-dependent anticoagulant effects in various species in vitro, doubling the activated partial thromboplastin time (aPTT), prothrombin time (PT) and ecarin clotting time (ECT) in human PPP at concentrations of 0.23, 0.83 and 0.18 microM, respectively [1]. in vivo: Dabigatran prolonged the aPTT dose-dependently after intravenous administration in rats (0.3, 1 and 3 mg/kg) and rhesus monkeys (0.15, 0.3 and 0.6 mg/kg). Dose- and time-dependent anticoagulant effects were observed with dabigatran etexilate administered orally to conscious rats (10, 20 and 50 mg/kg) or rhesus monkeys (1, 2.5 or 5 mg/kg), with maximum effects observed between 30 and 120 min after administration, respectively [1]. Patients treated with dabigatran etexilate experienced fewer ischaemic strokes (3.74 dabigatran etexilate vs 3.97 warfarin) and fewer combined intracranial haemorrhages and haemorrhagic strokes (0.43 dabigatran etexilate vs 0.99 warfarin) per 100 patient-years [2]. Clinical trial: An Evaluation of the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate in Hemodialysis Patients . Phase1

Storage

Powder

-20°C

3 years
 

4°C

2 years
In solvent

-80°C

6 months
 

-20°C

1 month

Clinical Trial

NCT Number Sponsor Condition Start Date

Phase

NCT02170792 Boehringer Ingelheim Healthy February 2001

Phase 1

NCT02170974 Boehringer Ingelheim Healthy July 2004

Phase 1

NCT02170831 Boehringer Ingelheim Healthy May 1999

Phase 1

NCT02170805 Boehringer Ingelheim Healthy April 2001

Phase 1

NCT02170610 Boehringer Ingelheim Healthy March 2002

Phase 1

NCT02170909 Boehringer Ingelheim Healthy December 2004

Phase 1

NCT02171000 Boehringer Ingelheim Healthy April 2005

Phase 1

NCT02170844 Boehringer Ingelheim Healthy June 2004

Phase 1

NCT02170584 Boehringer Ingelheim Healthy January 2001

Phase 1

NCT02170935 Boehringer Ingelheim Venous Thromboembolism April 2002

Phase 2

NCT02170636 Boehringer Ingelheim Healthy January 2002

Phase 1

NCT02170766 Boehringer Ingelheim Healthy October 2000

Phase 1

NCT02171442 Boehringer Ingelheim Healthy April 2002

Phase 1

NCT02170896 Boehringer Ingelheim Healthy October 2001

Phase 1

NCT02173730 Boehringer Ingelheim Healthy November 2002

Phase 1

NCT02170623 Boehringer Ingelheim Healthy February 2002

Phase 1

NCT02170116 Boehringer Ingelheim Healthy November 1998

Phase 1

NCT02170597 Boehringer Ingelheim Healthy August 2003

Phase 1

NCT01225822 Boehringer Ingelheim Venous Thromboembolism November 2002

Phase 2

NCT02170701 Boehringer Ingelheim Venous Thromboembolism October 2000

Phase 2

NCT02170740 Boehringer Ingelheim Healthy November 1999

Phase 1

NCT02170922 Boehringer Ingelheim Healthy July 1999

Phase 1

Chemical structure

Dabigatran Etexilate Mesylate

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

OUR STRENGTH

Quality management1

Proposal 18 Quality Consistency Evaluation projects which have approved 4, and 6 projects are under approving.

Quality management2

Advanced international quality management system has laid solid foundation for sales.

Quality management3

Quality supervision runs through the whole life cycle of the product to ensure the quality and therapeutic effect. 

Quality management4

Professional Regulatory Affairs team supports the quality demands during the application and registration.


VIEW MORE


VIEW MORE

International cooperation
International cooperation
Domestic cooperation
Domestic cooperation


Product detail pictures:

Good Quality Telaprevir Manufacturer - Dabigatran Etexilate Mesylate  – CPF detail pictures


Related Product Guide:

To continuously increase the administration process by virtue of the rule of "sincerely, good religion and excellent are the base of company development", we commonly absorb the essence of linked goods internationally, and continually build new solutions to fulfill the requires of shoppers for Good Quality Telaprevir Manufacturer - Dabigatran Etexilate Mesylate – CPF , The product will supply to all over the world, such as: Greece, Brasilia, Porto, Our products are very popular in the word, like South American, Africa, Asia and so on. Companies to "create first-class products" as the goal, and strive to provide customers with high quality products, provide high-quality after-sales service and technical support, and customer mutual benefit, create a better career and future!
  • This supplier's raw material quality is stable and reliable, has always been in accordance with the requirements of our company to provide the goods that quality meet our requirements.
    5 Stars By Antonio from Mombasa - 2018.12.30 10:21
    This is the first business after our company establish, products and services are very satisfying, we have a good start, we hope to cooperate continuous in the future!
    5 Stars By Alva from Lithuania - 2017.11.20 15:58
    Write your message here and send it to us